Skip to content
June 10, 2015 / Tetrahedroseph

Cannabis for Alzheimer’s disease

Patients for Medical Cannabis

A Molecular Link Between the Active Component of Marijuana and Alzheimer’s Disease Pathology

Alzheimer’s disease is the leading cause of dementia among the elderly, and with the ever-increasing size of this population, cases of Alzheimer’s disease are expected to triple over the next 50 years. Consequently, the development of treatments that slow or halt the disease progression have become imperative to both improve the quality of life for patients as well as reduce the health care costs attributable to Alzheimer’s disease. Here, we demonstrate that the active component of marijuana, Δ9-tetrahydrocannabinol (THC), competitively inhibits the enzyme acetylcholinesterase (AChE) as well as prevents AChE-induced amyloid β-peptide (Aβ) aggregation, the key pathological marker of Alzheimer’s disease. Computational modeling of the THC-AChE interaction revealed that THC binds in the peripheral anionic site of AChE, the critical region involved in amyloidgenesis. Compared to currently approved drugs prescribed for the treatment of Alzheimer’s…

View original post 1,293 more words

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

CryptoHub.Press

Cryptocurrency, Blockchain, & ICO News

Алексей Маркович

Писатель, переводчик, блогер

Bill Chance

This is Not Going to Turn Out Well

Through Open Lens

Home of Lukas Kondraciuk Photography

Little Fears

Tales of whimsy, humor and courgettes

Diary of an Aesthete

A Journey Of Heart And Mind

%d bloggers like this: